Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing dermatologic, advanced wound, and ...

Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the appointment of Matthew ...

Detailed price information for Nautilus Biotechnology Inc (NAUT-Q) from The Globe and Mail including charting and trades.

At the iGEM competition in Paris, high school and collegiate teams from around the world compete against one another with ...

Changes strategically aligned to support planned launch of Anaphylm™ (dibutepinephrine) Sublingual Film, if approved by the FDA, and to accelerate the Company’s ongoing development initiatives Matthew ...

Amid a slew of secondary equity raisings and at least two planned IPOs, the biotech sector is ending a difficult year on a ...

Geron Corporation , a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that Harout Semerjian, Chief Executive Officer, is ...

The more doctors learn about cancer, the more they realize that no two are the same. Some tumors respond to certain therapies, while others don't ...

Finance Minister Muhammad Aurangzeb said on Tuesday that Pakistan’s economy was in a “good spot”, attributing this to ...

LAWRENCEVILLE, N.J., Nov. 04, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that it will ...